Biological Activity of Metal Complexes: Design and Characterization Strategies

Dear Colleagues,

Metal complexes present an interesting field in biological applications due to their distinct properties and tunable design strategies. They boast anti-oxidant, antibacterial, anticancer, antiviral, antiparasitic, and enzyme-inhibitory actions, and medical practitioners have used these compounds as medicines and imaging agents because of their potential pharmacological activity. This Special Issue titled “Biological Activity of Metal Complexes: Design and Characterization Strategies” examines the makeup, properties, and mechanisms of these compounds, along with new research on how they are regulated and exert their biological actions. The use of metabolomics is crucial for the investigation of metal-based pharmaceutical action as it can identify the biomarkers that indicate whether a tumor is sensitive or resistant to these agents. On the other hand, transition metals (Fe, Cu, and Zn) play an essential role in various bioprocesses related to cognitive activity and neurodegenerative pathologies such as Alzheimer's disease. Also, metal complexes with antiproliferative activity have been extensively studied, and a few have elucidated different mechanisms of action and biological targets. However, it is still essential to discover and produce new metal-based compounds with lower toxicity and better biocompatibility. The relation between the chemical structure of potential metallodrugs and their biological activity is critical to uncovering the best therapeutic properties. Digging deeper, knowledge regarding the molecular interaction of metal-based compounds with biological macromolecules like serum albumin will help to design better and more selective agents that are less toxic, longer-lasting, and more effective in the bloodstream during therapy. Medicinal chemists have been encouraged to invest in the discovery of metal complexes as new chemical entities. Ideally, investigation of their biological activity should be pursued as a direct function of strategic design that entails an appropriate selection of ligands and metal centers, guided by robust experimental and computational characterization methods.

Prof. Dr. Enrique González-Vergara
Dr. María Eugenia Castro
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the Special Issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.